| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2022 | Jun 7, 2022 | Aprea Therapeutics, Inc. | CFO | Sell | 46.3 | -35,284 | -29.51% | ✗ | $28.4K |
| Feb 25, 2022 | Mar 1, 2022 | Aprea Therapeutics, Inc. | CFO | Sell | 46.3 | -14,817 | -16.20% | ✗ | $25.8K |
| Aug 25, 2021 | Aug 27, 2021 | Aprea Therapeutics, Inc. | CFO | Sell | 46.3 | -7,534 | -7.61% | ✗ | $30K |
| Oct 7, 2019 | Oct 7, 2019 | Aprea Therapeutics, Inc. | CFO | Buy | 91.3 | +2,500 | 100.00% | ✗ | $37.5K |